News & Events about Caredx Inc.
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today announced that the Journal of the American College of Cardiology (JACC): Heart...
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today announced its leading participation and top spot, for the...
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today reported preliminary financial results for the fourth quarter and full year...
CareDx, Inc (NASDAQ:CDNA Get Rating) insider Reginald Seeto sold 2,818 shares of the businesss stock in a transaction dated Tuesday, January 3rd. The shares were sold at an average price of $11.69, for a total transaction of $32,942.42. Following the completion of the transaction, the insider now ...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into CareDx, Inc. (NasdaqGM: CDNA). On October 28, 2021, the Company disclosed that it was the subject of at least...